<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="chapter-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><?noissn?><journal-meta><journal-id journal-id-type="nlm-ta">Scheuer's Liver Biopsy Interpretation</journal-id><journal-title-group><journal-title>Scheuer's Liver Biopsy Interpretation</journal-title></journal-title-group></journal-meta><article-meta><article-id pub-id-type="pmcid">7278535</article-id><article-id pub-id-type="publisher-id">B978-0-7020-7584-1.00006-1</article-id><article-id pub-id-type="doi">10.1016/B978-0-7020-7584-1.00006-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Acute Viral Hepatitis</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Lefkowitch</surname><given-names>Jay H.</given-names></name><degrees>MD</degrees></contrib><aff id="aff1">Professor of Pathology and Cell Biology, College of Physicians and Surgeons of Columbia University, New York</aff></contrib-group><pub-date pub-type="pmc-release"><day>5</day><month>6</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><year>2021</year></pub-date><pub-date pub-type="epub"><day>5</day><month>6</month><year>2020</year></pub-date><fpage>89</fpage><lpage>107</lpage><permissions><copyright-statement>Copyright &#x000a9; 2021 Elsevier Ltd. All rights reserved.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Elsevier Ltd</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="abs0010"><p>Acute viral hepatitis refers to hepatic infection by the hepatotropic viruses hepatitis A&#x02013;E. The acute infections look similar with regard to histologic features, with spotty necrosis throughout the lobules, hepatocyte unrest, swelling and apoptosis, and portal tract and intrasinusoidal inflammation, chiefly lymphocytes. The differential diagnosis histologically includes drug-induced liver injury. Structural differences and epidemiology define the major differences in the course of each of these viral infections. Hepatitis A and E are similar in causing only acute hepatitis, while some cases of hepatitis B and many of hepatitis C become chronic. The prevalence of hepatitis D virus (HDV) infection has seen a reduction worldwide due to hepatitis B vaccination programs. Nonetheless, major cities with continued intravenous drug use remain reservoirs with a rate of approximately 8% in Europe. The availability of direct-acting viral agents is spearheading efforts by WHO to eliminate new and chronic HCV infections by 2019. Histologic cholestasis may be a particular feature of acute hepatitis E. It should be noted that hepatitis E virus has four major genotypes of which 1 and 2 infect humans (resulting in travel/endemic-related hepatitis with cholestasis and high mortality in pregnant women) and 3 and 4 are zoonotic and infect pigs, boar and several other animal and avian species (and may cause hepatitis associated with poorly or uncooked meat).</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Bridging necrosis</kwd><kwd>Delta virus Hepatitis A virus</kwd><kwd>Hepatitis B virus</kwd><kwd>Hepatitis C virus</kwd><kwd>Hepatitis D virus</kwd><kwd>Hepatitis E virus</kwd><kwd>Spotty necrosis</kwd></kwd-group></article-meta></front><body><sec id="s0010"><title>Introduction</title><p id="p0010">Acute hepatitis is not usually an indication for liver biopsy. There are, however, at least three reasons why pathologists sometimes receive liver biopsy samples from patients with acute hepatitis. First, there may be doubt about the clinical diagnosis, or even a mistaken working diagnosis. Second, a diagnosis of hepatitis may be well established but the clinician needs information on the stage of the disease or its severity. Third, the patient may have received a liver transplant and the pathologist is being asked to help decide if symptoms or biochemical abnormalities are due to recurrent (or new) viral hepatitis or to some other cause such as rejection. For all these reasons, a knowledge of the pathology of acute hepatitis is essential. There is a further reason, no less important than the others: without a knowledge of acute hepatitis, the pathologist cannot hope to understand chronic hepatitis and cirrhosis, together the cause of most liver disease in the world. This chapter describes acute viral hepatitis and its immediate sequelae in the immunocompetent patient. The specific problems of diagnosing hepatitis in an immunosuppressed patient after transplantation are reviewed in <bold>Chapter 16</bold>.</p><p id="p0015">The hepatitis viruses are listed in <xref rid="t0010" ref-type="table">Table 6.1</xref>
. While several other candidates have been extensively investigated in recent years, none has so far been established as a definite cause of viral hepatitis, and most episodes of acute and chronic hepatitis can be attributed to one of the viruses listed, to autoimmune hepatitis (<bold>Ch. 9</bold>) or to a hepatotoxic agent (<bold>Ch. 8</bold>). An exception to this statement is fulminant hepatitis, the cause of which cannot currently be established in a substantial minority of patients,<xref rid="bib1" ref-type="bibr">1.</xref>, <xref rid="bib2" ref-type="bibr">2.</xref>, <xref rid="bib3" ref-type="bibr">3.</xref> including children.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> Occasionally, a virus more often associated with infection of other organs, such as one of the herpesviruses<xref rid="bib5" ref-type="bibr">5.</xref>, <xref rid="bib6" ref-type="bibr">6.</xref>, <xref rid="bib7" ref-type="bibr">7.</xref> or an adenovirus,<xref rid="bib8" ref-type="bibr">8.</xref>, <xref rid="bib9" ref-type="bibr">9.</xref> gives rise to a severe hepatitis. These agents are further discussed in <bold>Chapter 15</bold>. Mild acute hepatitis has been reported in patients infected with the SARS virus (severe acute respiratory syndrome-associated coronavirus).<xref rid="bib10" ref-type="bibr">10.</xref>, <xref rid="bib11" ref-type="bibr">11.</xref>
<table-wrap position="float" id="t0010"><label>Table 6.1</label><caption><p>The hepatitis viruses</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Virus</th><th>Type</th><th>Spread and disease</th></tr></thead><tbody><tr><td>Hepatitis A (HAV)</td><td>RNA hepatovirus</td><td>Faecal&#x02013;oral, acute</td></tr><tr><td>Hepatitis B (HBV)</td><td>DNA hepadnavirus</td><td>Parenteral, acute or chronic</td></tr><tr><td>Hepatitis C (HCV)</td><td>RNA hepacivirus</td><td>Parenteral or sporadic; acute, more often chronic</td></tr><tr><td>Hepatitis D (HDV)</td><td>RNA deltavirus, defective</td><td>Pathogenic when combined with HBV</td></tr><tr><td>Hepatitis E (HEV)</td><td>RNA virus</td><td>Faecal&#x02013;oral, epidemic or sporadic acute disease</td></tr></tbody></table></table-wrap></p><p id="p0020">Occasionally, mild serum liver test abnormalities and mild histological hepatitis (bystander hepatitis) with apoptotic bodies, focal necrosis and lymphocytic inflammation are seen in systemic, non-hepatic viral infections such as pulmonary influenza and result from migration to the liver of, and collateral damage by, CD8 T lymphocytes.<xref rid="bib12" ref-type="bibr">12.</xref>, <xref rid="bib13" ref-type="bibr">13.</xref>
</p></sec><sec id="s0015"><title>Pathological features</title><p id="p0025">The essential components of the acute phase of hepatitis are inflammatory-cell infiltration and hepatocellular damage. Other features include cholestasis, Kupffer-cell activation, endotheliitis, bile-duct damage, the ductular reaction and hepatocellular regeneration.
</p><sec id="s0020"><title>Hepatocellular damage</title><p id="p0030">Changes seen under the light microscope range from minor degrees of cell swelling to cell death. They are accompanied by the inflammatory infiltration described below, reflecting the important role of cellular immunity in the pathogenesis of most forms of hepatitis. Both hepatocellular damage and inflammation are usually most severe in perivenular areas, giving rise to a characteristic histological pattern (<xref rid="f0010" ref-type="fig">Fig. 6.1</xref>
). A periportal pattern of necrosis and inflammation, sometimes seen in hepatitis A, is less common.<fig id="f0010"><label>Fig. 6.1</label><caption><p>Acute viral hepatitis.</p><p>Surviving hepatocytes in the perivenular area in the centre of the field are swollen and the area is infiltrated by inflammatory cells.</p></caption><graphic xlink:href="f06-01-9780702075841"/><attrib>Needle biopsy, H&#x00026;E.</attrib></fig></p><p id="p0035">The mildest change is cell swelling, and this is probably reversible. The cytoplasm of affected cells is rarified, granular and sometimes finely vacuolated. The more severe degrees of cell swelling are called ballooning degeneration (<xref rid="f0015" ref-type="fig">Fig. 6.2</xref>
). This differs from the feathery degeneration of cholestasis, in which the cytoplasm has a reticular pattern (<bold>see</bold>
<xref rid="f0020" ref-type="fig">Fig. 5.3</xref>), and from the ballooning in steatohepatitis where the cytoplasm is less granular and more oedematous and &#x02018;clarified&#x02019; (<bold>see</bold>
<xref rid="f0055" ref-type="fig">Fig. 7.10C</xref>). Other hepatocytes undergo apoptosis, which is an important method of cell death in hepatitis.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> Shrinkage and increased staining of the cytoplasm, sometimes called acidophilic change or degeneration, is probably a precursor of apoptosis, in which the hepatocytes shrink further, become very dense and undergo fragmentation. The apoptotic bodies seen lying free in the sinusoids represent the largest fragments or entire unfragmented apoptotic cells (<xref rid="f0015" ref-type="fig">Fig. 6.2</xref>). They are also called acidophil bodies or Councilman bodies, Councilman having first described them in yellow fever<xref rid="bib15" ref-type="bibr">15.</xref>, <xref rid="bib16" ref-type="bibr">16.</xref> (<xref rid="f0020" ref-type="fig">Fig. 6.3</xref>
). Apoptotic bodies sometimes contain pyknotic nuclear remnants and often appear to bulge beyond the plane of the section. Another form of hepatocellular damage in acute hepatitis is focal (spotty) necrosis, in which liver-cell plates are disrupted or replaced by small groups of lymphocytes and macrophages. Whether these mark a site of necrosis or of apoptosis is not clear; the damage to hepatocytes is deduced from their absence rather than seen. Whatever its mechanism, loss of hepatocytes or liver-cell drop-out, coupled with focal regeneration, leads to a characteristic irregularity of the liver-cell plates, which usually allows acute hepatitis to be distinguished from hepatocellular damage secondary to cholestasis. The loss of hepatocytes also leads to condensation of the extracellular matrix, best seen in reticulin preparations (<xref rid="f0025" ref-type="fig">Fig. 6.4</xref>
).<fig id="f0015"><label>Fig. 6.2</label><caption><p>Acute viral hepatitis.</p><p>Normal liver-cell plate structure is disrupted. Hepatocytes vary in size, and some are ballooned and vacuolated. An apoptotic hepatocyte is seen left of centre.</p></caption><graphic xlink:href="f06-02-9780702075841"/><attrib>Needle biopsy, H&#x00026;E.</attrib></fig><fig id="f0020"><label>Fig. 6.3</label><caption><p>Acute yellow-fever hepatitis.</p><p>There is prominent mid-zonal necrosis (between arrows) with many apoptotic hepatocytes and scattered lymphocytes. The portal tract at lower right is mildly inflamed and there is relative preservation of periportal parenchyma. Inset: The numerous apoptotic (Councilman) bodies present (arrows) are characteristic of liver involvement in yellow fever.</p></caption><graphic xlink:href="f06-03-9780702075841"/><attrib>Case kindly provided by Dr Matthias Szabolcs, New York, NY.</attrib></fig><fig id="f0025"><label>Fig. 6.4</label><caption><p>Acute viral hepatitis.</p><p>The reticulin framework is condensed near the efferent venules (V) but not immediately around the portal tracts (P).</p></caption><graphic xlink:href="f06-04-9780702075841"/><attrib>Needle biopsy, reticulin.</attrib></fig></p><p id="p0040">Hepatocyte nuclei show prominent nucleoli and increased variation in size and may be multiple. When syncytial giant hepatocytes are very prominent, the term giant-cell hepatitis is appropriate.<xref rid="bib17" ref-type="bibr">17.</xref>, <xref rid="bib18" ref-type="bibr">18.</xref> This is only rarely of proven viral origin and is also more characteristic of acute hepatitis in neonates. In adults, autoimmune hepatitis and hepatitis C virus with or without human immunodeficiency virus co-infection are important associations.<xref rid="bib19" ref-type="bibr">19.</xref>, <xref rid="bib20" ref-type="bibr">20.</xref>, <xref rid="bib21" ref-type="bibr">21.</xref>, <xref rid="bib22" ref-type="bibr">22.</xref>, <xref rid="bib23" ref-type="bibr">23.</xref>
</p><p id="p0045">Cholestasis in the form of bile thrombi in canaliculi is common in acute hepatitis but rare in chronic hepatitis, which is diagnostically helpful. It is a result of damage to the bile-secretory apparatus of the hepatocytes, but may also result from interference with bile flow at the level of the portal tracts.<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> The term cholestatic hepatitis is best kept as a clinical description of patients with a prolonged cholestatic course. Mild hepatocellular siderosis or steatosis is occasionally seen.
</p></sec><sec id="s0025"><title>The inflammatory infiltrate</title><p id="p0050">Unlike classic acute inflammation, viral hepatitis is characterised by a mainly lymphocytic infiltrate within the parenchyma and portal tracts. In acute hepatitis, the most conspicuous inflammation is usually perivenular. The extent of portal inflammation is very variable, and portal tracts may be either normal in size or expanded. The larger conducting tracts are often spared. The edges of small portal tracts may be well defined or blurred by outward extension of the infiltrate. This so-called spillover resembles the interface hepatitis of chronic hepatitis (<bold>Ch. 9</bold>) and may be difficult to distinguish from it. The parenchymal changes, clinical history and virological findings usually make the correct diagnosis clear.</p><p id="p0055">While most of the infiltrating cells in acute hepatitis are small T lymphocytes,<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> plasma cells may also be prominent,<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> and there are often a few neutrophils and eosinophils. The plasma cells do not necessarily indicate autoimmune hepatitis, nor do a few eosinophils prove a diagnosis of drug injury. Kupffer cells and other macrophages accumulate and enlarge, many of them forming discrete clumps together with lymphocytes. They may contain tan-brown ceroid pigment, staining with periodic acid&#x02013;Schiff (PAS) agent after diastase digestion (<xref rid="f0030" ref-type="fig">Fig. 6.5</xref>
). They may also contain stainable iron (<xref rid="f0035" ref-type="fig">Fig. 6.6</xref>
), but this is less common.<fig id="f0030"><label>Fig. 6.5</label><caption><p>Acute viral hepatitis.</p><p>Macrophages contain diastase periodic acid&#x02013;Schiff (PAS)-positive material.</p></caption><graphic xlink:href="f06-05-9780702075841"/><attrib>Needle biopsy, diastase&#x02013;PAS.</attrib></fig><fig id="f0035"><label>Fig. 6.6</label><caption><p>Acute viral hepatitis.</p><p>Enlarged macrophages are strongly iron positive. Some endothelial cells also contain dense Perls&#x02019; stain-positive granules. (Section kindly provided by Dr Susan Davies, Cambridge, UK.)</p></caption><graphic xlink:href="f06-06-9780702075841"/><attrib>Needle biopsy, Perls&#x02019; stain.</attrib></fig></p><p id="p0060">Sinusoidal and venular endothelial cells also take part in the hepatitic process. Sinusoidal endothelial cells become swollen and may contain dense iron-positive granules<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> (<xref rid="f0035" ref-type="fig">Fig. 6.6</xref>). Terminal hepatic venules may show disruption of the endothelium and lymphocytic infiltration.</p></sec><sec id="s0030"><title>Portal changes</title><p id="p0065">In contrast to chronic hepatitis, the parenchymal changes dominate the picture, but there is always some portal inflammation, affecting most or all of the small portal tracts (<xref rid="f0040" ref-type="fig">Fig. 6.7</xref>
). The density of the infiltrate varies. Interlobular bile ducts may show abnormalities, including irregularity, crowding and stratification of the epithelium, cytoplasmic vacuolation and infiltration by lymphocytes (<xref rid="f0045" ref-type="fig">Fig. 6.8</xref>
). These changes, together with formation of dense lymphoid structures (aggregates and follicles), are most often seen in hepatitis C. Bile-duct loss (ductopenia) is very rare.<fig id="f0040"><label>Fig. 6.7</label><caption><p>Acute viral hepatitis.</p><p>A portal tract is infiltrated by inflammatory cells, mainly lymphocytes. In places the infiltrate extends a short way into the adjacent parenchyma.</p></caption><graphic xlink:href="f06-07-9780702075841"/><attrib>Needle biopsy, H&#x00026;E.</attrib></fig><fig id="f0045"><label>Fig. 6.8</label><caption><p>Acute viral hepatitis.</p><p>Bile-duct epithelium is irregular and infiltrated by lymphocytes. The upper duct profile shows epithelial atrophy and dilatation.</p></caption><graphic xlink:href="f06-08-9780702075841"/><attrib>Wedge biopsy, H&#x00026;E.</attrib></fig></p></sec><sec id="s0035"><title>Histological variants</title><p id="p0070">The histological changes in acute hepatitis are infinitely variable, but a few patterns deserve special mention. These are confluent necrosis, bridging necrosis, necrosis of entire lobules and periportal necrosis.</p><p id="p0075">
<bold>Confluent necrosis</bold> signifies death of a substantial area of the parenchyma. Focal as opposed to zonal areas of confluent necrosis haphazardly distributed in relation to lobular zones are more likely to be due to causes other than acute viral hepatitis; possibilities to be considered include opportunistic infections with herpes simplex or zoster viruses and lymphoma. <bold>Bridging necrosis</bold> (<xref rid="f0055" ref-type="fig">Fig. 6.10</xref>, <xref rid="f0050" ref-type="fig">Fig. 6.9</xref>
<bold>, and see</bold>
<xref rid="f0045" ref-type="fig">Fig. 4.8</xref>) is the term given to confluent necrosis linking terminal venules to portal tracts. A possible explanation for this location is that it represents the entire zone 3 of an acinus, a view supported by the curved shape of many bridges. Bridging necrosis is a manifestation of severe acute hepatitis, but its distribution even within a single biopsy may be irregular. Necrosis and inflammation linking adjacent portal tracts without involvement of terminal venules should not strictly be called bridging because it almost certainly has different pathogenetic significance; it results from widening of portal tracts, with or without periportal necrosis.<fig id="f0055"><label>Fig. 6.10</label><caption><p>Acute viral hepatitis: bridging necrosis.</p><p>Recent collapse following confluent necrosis is seen as condensation of reticulin, mimicking fibrosis.</p></caption><graphic xlink:href="f06-10-9780702075841"/><attrib>Needle biopsy, reticulin.</attrib></fig><fig id="f0050"><label>Fig. 6.9</label><caption><p>Acute viral hepatitis: bridging necrosis.</p><p>Two curved lines of collapse (arrows) extend from a portal tract (P). An efferent venule (V) is seen top centre.</p></caption><graphic xlink:href="f06-09-9780702075841"/><attrib>Needle biopsy, H&#x00026;E.</attrib></fig></p><p id="p0080">Bridges of confluent necrosis with subsequent collapse may be mistaken for the septa of chronic liver disease. In making the important distinction between them, the pathologist is often helped by stains for elastic tissue. Unlike stains for collagens, these normally give negative results in the parenchyma, but elastic tissue accumulates as septa age.<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> Recent collapse is therefore negative (<xref rid="f0060" ref-type="fig">Fig. 6.11</xref>
), whereas old septa are positive. Substantial amounts of elastic tissue take months or years to accumulate, but small amounts can be detected by sensitive methods such as Victoria blue as early as 1 or 2 months after onset of hepatitis.<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref>
<fig id="f0060"><label>Fig. 6.11</label><caption><p>Acute hepatitis: bridging necrosis.</p><p>The field is the same as that shown in <xref rid="f0055" ref-type="fig">Fig. 6.10</xref>. A stain for elastic fibres is positive in two portal tracts (P) but not in the intervening area of collapse. A necrotic bridge (arrow) is also negative. Inset: This contrasts with an elastic fibre-rich septum in chronic liver disease.</p></caption><graphic xlink:href="f06-11-9780702075841"/><attrib>Needle biopsy, orcein.</attrib></fig></p><p id="p0085">In a minority of patients with acute viral hepatitis, confluent necrosis extends throughout entire lobules or acini (<bold>panlobular</bold> or <bold>panacinar necrosis</bold>) or several adjacent ones (<bold>multilobular</bold> or <bold>multiacinar necrosis</bold>). This is a common feature in patients with fulminant hepatitis. The term &#x02018;massive necrosis&#x02019; is also sometimes used, but can be misleading in so far as a needle biopsy specimen may not be representative of the liver as a whole and can lead to over- or underestimation of the true extent of liver damage.<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> This throws doubt on the usefulness of liver biopsy as a means of assessing prognosis in severe acute hepatitis. Sometimes multilobular necrosis involves only the subcapsular zone, and a small needle specimen may then give a falsely pessimistic picture (<bold>see</bold>
<bold>Fig. 1.3</bold>). In multilobular necrosis the parenchyma is replaced by collapsed stroma, inflammatory cells and activated macrophages (<xref rid="f0065" ref-type="fig">Fig. 6.12</xref>
). Around the surviving portal tracts there are prominent duct-like structures, some of which probably represent proliferation of pluripotential progenitor cells<xref rid="bib31" ref-type="bibr">31.</xref>, <xref rid="bib32" ref-type="bibr">32.</xref>, <xref rid="bib33" ref-type="bibr">33.</xref> (<bold>see</bold>
<xref rid="f0070" ref-type="fig">Fig. 4.13D</xref>). &#x02018;Late-onset hepatic failure&#x02019; is a term used for patients developing encephalopathy between 8 and 24 weeks after onset of symptoms.<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> Study of liver biopsies and explanted livers from these patients has shown a consistent pattern of map-like necrosis together with areas of nodular regeneration.<fig id="f0065"><label>Fig. 6.12</label><caption><p>Acute viral hepatitis: multilobular necrosis.</p><p>Portal tracts (P) can be identified, but the parenchyma has been replaced by inflammatory cells, necrotic debris and duct-like structures.</p></caption><graphic xlink:href="f06-12-9780702075841"/><attrib>Needle biopsy, H&#x00026;E.</attrib></fig></p><p id="p0090">Periportal necrosis rather than the more usual perivenular necrosis is a feature in some patients with hepatitis A (discussed later).</p></sec></sec><sec id="s0040"><title>Individual causes of viral hepatitis</title><p id="p0095">There are more similarities than differences between hepatitis types A, B, C, D and E, but certain patterns are more common in one type than another and are described here. They do not allow the pathologist to identify the cause of the hepatitis on histological appearance alone. The picture may be confused by the presence of more than one virus, or by additional damage resulting from alcohol abuse.</p><sec id="s0045"><title>Hepatitis A</title><p id="p0100">Two main patterns are described, occurring separately or together.<xref rid="bib35" ref-type="bibr">35.</xref>, <xref rid="bib36" ref-type="bibr">36.</xref>, <xref rid="bib37" ref-type="bibr">37.</xref> One is a histological picture of perivenular cholestasis with little liver-cell damage or inflammation, easily mistaken for other causes of cholestasis (<xref rid="f0070" ref-type="fig">Fig. 6.13</xref>
). The second is a hepatitis with periportal necrosis and a dense portal infiltrate which includes abundant, often aggregated plasma cells (<xref rid="f0075" ref-type="fig">Fig. 6.14</xref>
). These two patterns may be related, the cholestasis resulting from interruption of bile flow by the periportal necrosis.<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> Other patterns of hepatitis as described earlier are also found, but fulminant hepatitis with multilobular necrosis is rare. Extensive microvesicular change of hepatocytes, previously described in hepatitis D infection, has been seen also in severe acute hepatitis A (<xref rid="f0080" ref-type="fig">Fig. 6.15</xref>
). Fibrin-ring granulomas have been reported.<xref rid="bib38" ref-type="bibr">38.</xref>, <xref rid="bib39" ref-type="bibr">39.</xref> A chronic course<xref rid="bib40" ref-type="bibr"><sup>40</sup></xref> is very rare.<fig id="f0070"><label>Fig. 6.13</label><caption><p>Hepatitis A.</p><p>Perivenular area showing irregularity of liver-cell plates and cholestasis but only mild inflammatory infiltration.</p></caption><graphic xlink:href="f06-13-9780702075841"/><attrib>Needle biopsy, H&#x00026;E.</attrib></fig><fig id="f0075"><label>Fig. 6.14</label><caption><p>Hepatitis A.</p><p>The portal area at right is heavily infiltrated by lymphocytes and plasma cells, some of which extend into the adjacent parenchyma. The limiting plate is irregular. The picture resembles that of chronic hepatitis with interface hepatitis.</p></caption><graphic xlink:href="f06-14-9780702075841"/><attrib>Needle biopsy, H&#x00026;E.</attrib></fig><fig id="f0080"><label>Fig. 6.15</label><caption><p>Hepatitis A.</p><p>In this patient with a clinical picture of fulminant hepatitis, hepatocytes are swollen and microvesicular. There is cholestasis and a lymphocytic infiltrate.</p></caption><graphic xlink:href="f06-15-9780702075841"/><attrib>Needle biopsy, H&#x00026;E.</attrib></fig></p></sec><sec id="s0050"><title>Hepatitis B</title><p id="p0105">The histological appearances are broadly similar to those of other forms of viral hepatitis. Some of the differences reported in the literature may well reflect patient selection rather than features specific for hepatitis B virus (HBV) infection. However, lymphocytes and macrophages sometimes lie in close contact with hepatocytes (peripolesis) or even invaginate them deeply (emperipolesis), which probably reflects the immunological nature of the cell damage. In a comparative study, periportal inflammation tended to be more severe in acute hepatitis B than in hepatitis C.<xref rid="bib41" ref-type="bibr"><sup>41</sup></xref> Liver cells and their nuclei may show a moderate degree of pleomorphism. In most cases of acute hepatitis, the hepatitis B core and surface antigens (HBcAg and HBsAg) are either not demonstrable or very sparse, but in one study of livers infected with an HBV mutant,<xref rid="bib42" ref-type="bibr"><sup>42</sup></xref> HBsAg could be demonstrated by immunostaining in over half of the patients and HBcAg in a minority. The presence of ground-glass hepatocytes (<bold>Ch. 9</bold>) or positive staining of surface material with Victoria blue or orcein indicates chronic disease. Recurrence of HBV infection after liver transplantation is an exception to this rule, both antigens being found in large amounts (<bold>see</bold>
<bold>Ch. 16</bold>). In parenterally transmitted hepatitis, including types B and C, birefringent spicules of talc may be found in portal tracts as a result of intravenous drug abuse.<xref rid="bib42" ref-type="bibr"><sup>42</sup></xref>
</p><p id="p0110">Following clinical recovery of acute hepatitis B, occult infection and mild histological abnormalities including portal inflammation, focal necrosis, apoptosis and fibrosis may persist for at least a decade.<xref rid="bib43" ref-type="bibr"><sup>43</sup></xref>
</p><p id="p0115">
<bold>Reactivation</bold> of a previously occult or quiescent chronic hepatitis B infection may cause changes closely resembling acute hepatitis. In such instances the presence of (1) portal tract lymphoid aggregates, (2) significant lymphoplasmacytic interface hepatitis, (3) any evidence of fibrosis on connective tissue stains and (4) substantial positivity of HBsAg in hepatocytes on immunostaining points to the underlying chronicity of the process.</p></sec><sec id="s0055"><title>Hepatitis C</title><p id="p0120">Usually the histological features of hepatitis C are those of any acute hepatitis, but two distinguishing features have been noted. First, there may be prominent infiltration of sinusoids by lymphocytes in the absence of severe liver-cell damage,<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref> giving rise to a picture reminiscent of infectious mononucleosis (<xref rid="f0085" ref-type="fig">Fig. 6.16</xref>
). Second, lymphoid follicles and bile-duct damage, features also associated with chronic hepatitis, may be seen within a few weeks or months of onset.<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref> There may be cholestasis. The common finding of steatosis in hepatitis C is discussed in <bold>Chapter 9</bold>. Fulminant hepatitis C is very rare in the Western world,<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> but may be commoner in parts of Asia.<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref>
<fig id="f0085"><label>Fig. 6.16</label><caption><p>Acute hepatitis C.</p><p>In this example the main abnormality is infiltration of sinusoids by lymphocytes.</p></caption><graphic xlink:href="f06-16-9780702075841"/><attrib>Needle biopsy, H&#x00026;E.</attrib></fig></p></sec><sec id="s0060"><title>Hepatitis D (delta hepatitis)</title><p id="p0125">Co-infection or superinfection with the hepatitis D virus (HDV) alters the course of type B hepatitis. It encourages chronicity and enhances severity,<xref rid="bib47" ref-type="bibr">47.</xref>, <xref rid="bib48" ref-type="bibr">48.</xref>, <xref rid="bib49" ref-type="bibr">49.</xref> except after liver transplantation. The antigen, HDAg, can easily be demonstrated immunohistochemically in paraffin sections and is mainly found in hepatocyte nuclei (<xref rid="f0090" ref-type="fig">Fig. 6.17</xref>
). These may have finely granular eosinophilic centres (so-called sanded nuclei<xref rid="bib50" ref-type="bibr"><sup>50</sup></xref>). Cytoplasmic and membrane-associated staining is also sometimes seen.<fig id="f0090"><label>Fig. 6.17</label><caption><p>Delta hepatitis (HDV).</p><p>Some hepatocyte nuclei contain the delta antigen and are stained red. There is a substantial lymphocytic infiltrate.</p></caption><graphic xlink:href="f06-17-9780702075841"/><attrib>Needle biopsy, specific immunostain, alkaline phosphatase method.</attrib></fig></p><p id="p0130">Severe acute hepatitis in a patient with markers of HBV infection may be due to superinfection by HDV of a chronic HBV carrier.<xref rid="bib51" ref-type="bibr"><sup>51</sup></xref> In an outbreak of HDV infection among Venezuelan Indians, notable features included early small-droplet fatty change, sparse lymphocytes and abundant macrophages in the parenchyma, and substantial portal infiltration.<xref rid="bib52" ref-type="bibr"><sup>52</sup></xref> Later in the attack, there was extensive necrosis and collapse. Microvesicular fatty change and acidophilic necrosis of hepatocytes have been reported from Colombia<xref rid="bib53" ref-type="bibr"><sup>53</sup></xref> and North America.<xref rid="bib54" ref-type="bibr"><sup>54</sup></xref> In non-immunosuppressed patients with current HDV infection, liver biopsy is likely to show substantial necrosis and inflammation. However, there are HDV-endemic regions where the virus produces little significant disease.<xref rid="bib55" ref-type="bibr"><sup>55</sup></xref> Following liver transplantation, by contrast, HDV without HBV is sometimes demonstrable in the absence of hepatitic changes, indicating that HDV can survive in the absence of HBV. It does not then appear, however, to be capable of causing liver damage.<xref rid="bib56" ref-type="bibr"><sup>56</sup></xref>
</p></sec><sec id="s0065"><title>Hepatitis E virus LBI-10</title><p id="p0135">Hepatitis E virus (HEV) is an RNA virus with eight currently described genotypes, five of which can infect humans (genotypes 1, 2, 3, 4, and 7).<xref rid="bib57" ref-type="bibr">57.</xref>, <xref rid="bib101" ref-type="bibr">58a.</xref> Genotypes 1 and 2 are restricted to higher primates and humans and are associated with epidemic outbreaks and an oral-faecal transmission mode, while genotypes 3-8 show a broad mammalian phylogenetic reservoir including pigs, boar, deer, rodents, ferrets, bats, cattle, sheep, foxes, dromedary camels and horses and cause zoonotic, autochthonous (i.e., acquired regionally) infections, typically through poorly or undercooked meat.<xref rid="bib102" ref-type="bibr">58b.</xref>, <xref rid="bib103" ref-type="bibr">58c.</xref> HEV has caused epidemics in Asia and has also been found in Africa, North and South America and Europe. Infections with genotypes 1 and 2 resulted in an estimated &#x0003e;3 million symptomatic cases and 70,000 fatalities in endemic regions in 2005.<xref rid="bib104" ref-type="bibr">59a.</xref>, <xref rid="bib105" ref-type="bibr">59b.</xref> Autochthonous HEV infections, among which genotype 3 is the most common, have caused acute hepatitis in North America and Europe<xref rid="bib57" ref-type="bibr">57.</xref>, <xref rid="bib60" ref-type="bibr">60.</xref> but sometimes is misdiagnosed as drug-induced liver injury.<xref rid="bib106" ref-type="bibr">61a.</xref>, <xref rid="bib107" ref-type="bibr">61b.</xref>, <xref rid="bib108" ref-type="bibr">61c.</xref> Chronic hepatitis E has been described in organ transplant recipients and other immunosuppressed individuals.<xref rid="bib62" ref-type="bibr">62.</xref>, <xref rid="bib109" ref-type="bibr">63a.</xref>, <xref rid="bib110" ref-type="bibr">63b.</xref>
</p><p id="p2935">Information about the pathology of HEV infection in humans is emerging,<xref rid="bib101" ref-type="bibr">58a.</xref>, <xref rid="bib106" ref-type="bibr">61a.</xref>, <xref rid="bib111" ref-type="bibr">63c.</xref> although many of the histological features are similar to those seen in other types of viral hepatitis or in autoimmune or drug-induced hepatitis.<xref rid="bib101" ref-type="bibr">58a.</xref>, <xref rid="bib106" ref-type="bibr">61a.</xref> The morphology depends on the HEV viral genotype and on the clinicopathological setting<xref rid="bib101" ref-type="bibr">58a.</xref>, <xref rid="bib109" ref-type="bibr">63a.</xref>, <xref rid="bib64" ref-type="bibr">64.</xref>, <xref rid="bib65" ref-type="bibr">65.</xref>, <xref rid="bib66" ref-type="bibr">66.</xref>, <xref rid="bib67" ref-type="bibr">67.</xref> (see <xref rid="b0010" ref-type="boxed-text">Box 6.1</xref>
). Foci of lobular necroinflammation with intrasinusoidal pigmented, ceroid-laden Kupffer cells are prominent in the acute infection (<xref rid="f0095" ref-type="fig">Fig. 6.18</xref>
).<xref rid="bib101" ref-type="bibr">58a</xref>
<italic>Epidemic (genotype 1 or 2) hepatitis E</italic> is well known for its potential for severe hepatic disease, acute liver failure and massive hepatic necrosis, but some cases have shown prolonged clinical cholestasis with bile canalicular cholestasis and cholestatic rosettes on biopsy. The changes may resemble those of hepatitis A, with prominent cholestasis and a predominantly portal and periportal inflammatory infiltrate.<xref rid="bib68" ref-type="bibr">68</xref> In one study, a pregnant woman with fatal epidemic hepatitis E the liver showed little portal inflammation, much cholestasis with prominent portal vein and central vein endotheliitis and viral particles were identified in bile ductules by electron microscopy.<xref rid="bib69" ref-type="bibr">69</xref>
<italic>Cases of autochthonous hepatitis E (usually genotype 3)</italic> have shown portal lymphoid aggregates and periportal ductular reaction with neutrophilia at the edges of portal tracts.60 In immunocompromised subjects with organ transplants, immundeficiencies or corticosteroid therapy, <italic>chronic hepatitis E</italic> manifests with the classical features of chronic hepatitis (i.e., interface hepatitis with variable lobular necroinflammation), but portal tract neutrophilia with bile duct damage, or even destruction, may be prominent.<xref rid="bib70" ref-type="bibr">70</xref>
<boxed-text id="b0010"><label>Box 6.1</label><caption><title>Major clinicopathological settings of HEV infection</title></caption><p id="bpar0010">
<list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#x02022;</label><p id="bpar0015">Acute, epidemic (genotype 1 or 2) hepatitis E</p></list-item><list-item id="u0015"><label>&#x02022;</label><p id="bpar0020">Acute autochthonous (genotype 3 or 4-7) hepatitis E</p></list-item><list-item id="u0020"><label>&#x02022;</label><p id="bpar0025">Acute hepatitis E superimposed on pre-existing chronic liver disease</p></list-item><list-item id="u0025"><p id="bpar0030">(acute-on-chronic liver disease)</p></list-item><list-item id="u0030"><label>&#x02022;</label><p id="bpar0035">Acute or chronic hepatitis E in immunocompromised host (e.g., organ transplant recipients; chemotherapy administration; HIV positivity)</p></list-item><list-item id="u0035"><label>&#x02022;</label><p id="bpar0040">Chronic hepatitis E</p></list-item></list>
</p></boxed-text><fig id="f0095"><label>Fig. 6.18</label><caption><p>Hepatitis E.</p><p>Hepatocytes are vacuolated and one to the left of centre is greatly enlarged and multinucleated. There is a mixed infiltrate, and macrophages contain brown ceroid pigment.</p></caption><graphic xlink:href="f06-18-9780702075841"/><attrib>Needle biopsy, H&#x00026;E.</attrib></fig></p><p id="p0140">Detection of HEV infection in liver tissue can be accomplished by polymerase chain reaction (PCR) assessment for HEV RNA, or by immunohistochemistry for open reading frames (ORFs) 1-3 (especially ORF 2) and by in situ hybridization for HEV RNA.<xref rid="bib71" ref-type="bibr">71.</xref>, <xref rid="bib72" ref-type="bibr">72.</xref> Recent efforts to produce a vaccine have shown promise, but the only existing vaccine (vaccine 239) is currently only licensed in China.<xref rid="bib73" ref-type="bibr">73.</xref>, <xref rid="bib74" ref-type="bibr">74.</xref>, <xref rid="bib75" ref-type="bibr">75.</xref>, <xref rid="bib76" ref-type="bibr">76.</xref>
</p></sec></sec><sec id="s0070"><title>Differential diagnosis of acute viral hepatitis</title><p id="p0145">The distinction of acute hepatitis from bile-duct obstruction rests mainly on the finding of typical hepatitic changes in the parenchyma. The portal tract oedema of duct obstruction is absent. Drug-related hepatitis may be indistinguishable from viral hepatitis and should always be suspected if the cause of the hepatitis is in doubt. Features more common in drug-induced than in viral hepatitis include sharply defined perivenular necrosis, granulomas, bile-duct damage, abundant neutrophils or eosinophils and a poorly developed portal inflammatory reaction. Cholestasis may overshadow the hepatitic features. Autoimmune hepatitis may have a clinically acute onset, histologically indistinguishable from viral hepatitis or alternatively with histological features of chronic disease. This is discussed more fully in <bold>Chapter 9</bold>. In steatohepatitis there is usually conspicuous fatty change. Mallory bodies may be present in ballooned hepatocytes, and the infiltrate typically includes neutrophils. The key to the diagnosis is the presence of pericellular fibrosis in affected areas. The differentiation of acute from chronic hepatitis is briefly discussed under bridging necrosis in <bold>Chapter 4</bold>. While the parenchymal changes predominate in acute hepatitis, especially in perivenular areas, portal and periportal changes predominate in chronic disease. The distinction is sometimes difficult to make, especially when extensive lobular changes are found during an exacerbation of chronic hepatitis or in reactivated chronic hepatitis B, as described earlier.</p></sec><sec id="s0075"><title>Fate and morphological sequelae of acute viral hepatitis</title><sec id="s0080"><title>Resolution</title><p id="p0150">As far as can be deduced from the available evidence, most examples of hepatitis A, B and E are followed by complete or near-complete resolution and a return of the liver to normal. A chronic course is probably more common when hepatitis B is complicated by delta infection than otherwise, and in hepatitis C the risk of chronicity is high. Even in patients whose hepatitis resolves, some residual changes may persist for many months after clinical recovery (<xref rid="f0100" ref-type="fig">Fig. 6.19</xref>, <xref rid="f0105" ref-type="fig">Fig. 6.20</xref>
).<fig id="f0100"><label>Fig. 6.19</label><caption><p>Acute viral hepatitis: residual changes.</p><p>Short septa extend from the mildly inflamed portal tract to the left. Minimal inflammation and irregular liver-cell plates are seen around the efferent venule below right.</p></caption><graphic xlink:href="f06-19-9780702075841"/><attrib>Needle biopsy, H&#x00026;E.</attrib></fig><fig id="f0105"><label>Fig. 6.20</label><caption><p>Acute viral hepatitis: residual changes.</p><p>Slender septa link portal tracts (left and right), but the perivenular area (centre) is unaffected and architectural relationships are preserved.</p></caption><graphic xlink:href="f06-20-9780702075841"/><attrib>Needle biopsy, reticulin.</attrib></fig></p></sec><sec id="s0085"><title>Scarring</title><p id="p0155">Localised collapse, scarring and regeneration following severe hepatitis with bridging or panlobular necrosis sometimes produce a histological picture indistinguishable from cirrhosis.
</p></sec><sec id="s0090"><title>Fatal outcome or need for liver transplantation</title><p id="p0160">Necrosis is usually severe. Regenerative hyperplasia of surviving hepatocytes or progenitor cells may be seen.</p></sec><sec id="s0095"><title>Chronic hepatitis</title><p id="p0165">In regions where HBV vaccine programs have not been instituted, many individuals will develop chronic hepatitis B. The availability of direct-acting antiviral agents to treat acute hepatitis C virus infections is likely to dramatically reduce the prevalence of chronic hepatitis C in the future.</p></sec><sec id="s0100"><title>Cirrhosis</title><p id="p0170">Cirrhosis resulting from infection with a hepatitis virus almost always follows a period of chronic hepatitis, with repeated or continuous hepatocellular necrosis and regeneration. Occasionally it may follow directly after a single episode of severe acute hepatitis where it is termed &#x02018;postnecrotic cirrhosis&#x02019;.</p></sec><sec id="s0105"><title>Hepatocellular carcinoma</title><p id="p0175">This may develop on the basis of cirrhosis in patients infected with HBV or hepatitis C virus. Occasionally, however, hepatocellular carcinoma is found in the absence of cirrhosis, usually after a prolonged period of chronic liver disease<xref rid="bib76" ref-type="bibr"><sup>76</sup></xref> (although the risk appears to be even greater in non-cirrhotic patients with non-alcoholic steatohepatitis).<xref rid="bib77" ref-type="bibr">77.</xref>, <xref rid="bib78" ref-type="bibr">78.</xref>
</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1.</label><element-citation publication-type="journal" id="ref0010"><person-group person-group-type="author"><name><surname>Ben-Ari</surname><given-names>Z.</given-names></name><name><surname>Samuel</surname><given-names>D.</given-names></name><name><surname>Zemel</surname><given-names>R.</given-names></name></person-group><article-title>Fulminant non-A-G viral hepatitis leading to liver transplantation</article-title><source>Arch Intern Med</source><volume>160</volume><year>2000</year><fpage>388</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">10668842</pub-id></element-citation></ref><ref id="bib2"><label>2.</label><element-citation publication-type="journal" id="ref0015"><person-group person-group-type="author"><name><surname>Petrovic</surname><given-names>L.M.</given-names></name><name><surname>Arkadopoulos</surname><given-names>N.</given-names></name><name><surname>Demetriou</surname><given-names>A.A.</given-names></name></person-group><article-title>Activation of hepatic stellate cells in liver tissue of patients with fulminant liver failure after treatment with bioartificial liver</article-title><source>Hum Pathol</source><volume>32</volume><year>2001</year><fpage>1371</fpage><lpage>1375</lpage><pub-id pub-id-type="pmid">11774171</pub-id></element-citation></ref><ref id="bib3"><label>3.</label><element-citation publication-type="journal" id="ref0020"><person-group person-group-type="author"><name><surname>Schi&#x000f8;dt</surname><given-names>F.V.</given-names></name><name><surname>Davern</surname><given-names>T.J.</given-names></name><name><surname>Shakil</surname><given-names>A.O.</given-names></name></person-group><article-title>Viral hepatitis-related acute liver failure</article-title><source>Am J Gastroenterol</source><volume>98</volume><year>2003</year><fpage>448</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">12591067</pub-id></element-citation></ref><ref id="bib4"><label>4.</label><element-citation publication-type="journal" id="ref0025"><person-group person-group-type="author"><name><surname>Kirsch</surname><given-names>R.</given-names></name><name><surname>Yap</surname><given-names>J.</given-names></name><name><surname>Roberts</surname><given-names>E.A.</given-names></name></person-group><article-title>Clinicopathologic spectrum of massive and submassive hepatic necrosis in infants and children</article-title><source>Hum Pathol</source><volume>40</volume><year>2009</year><fpage>516</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">19121848</pub-id></element-citation></ref><ref id="bib5"><label>5.</label><element-citation publication-type="journal" id="ref0030"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>D.J.</given-names></name><name><surname>Greene</surname><given-names>W.H.</given-names></name><name><surname>Ruggiero</surname><given-names>F.</given-names></name></person-group><article-title>Herpes simplex-induced fulminant hepatitis in adults: a call for empiric therapy</article-title><source>Dig Dis Sci</source><volume>45</volume><year>2000</year><fpage>2399</fpage><lpage>2404</lpage><pub-id pub-id-type="pmid">11258565</pub-id></element-citation></ref><ref id="bib6"><label>6.</label><element-citation publication-type="journal" id="ref0035"><person-group person-group-type="author"><name><surname>Pinna</surname><given-names>A.D.</given-names></name><name><surname>Rakela</surname><given-names>J.</given-names></name><name><surname>Demetris</surname><given-names>A.J.</given-names></name></person-group><article-title>Five cases of fulminant hepatitis due to herpes simplex virus in adults</article-title><source>Dig Dis Sci</source><volume>47</volume><year>2002</year><fpage>750</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">11991604</pub-id></element-citation></ref><ref id="bib7"><label>7.</label><element-citation publication-type="journal" id="ref0040"><person-group person-group-type="author"><name><surname>Collin</surname><given-names>L.</given-names></name><name><surname>Moulin</surname><given-names>P.</given-names></name><name><surname>Jungers</surname><given-names>M.</given-names></name></person-group><article-title>Epstein&#x02013;Barr virus (EBV)-induced liver failure in the absence of extensive liver-cell necrosis: a case for cytokine-induced liver dysfunction?</article-title><source>J Hepatol</source><volume>41</volume><year>2004</year><fpage>174</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">15246231</pub-id></element-citation></ref><ref id="bib8"><label>8.</label><element-citation publication-type="journal" id="ref0045"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.H.</given-names></name><name><surname>Wang</surname><given-names>H.L.</given-names></name></person-group><article-title>Fulminant adenovirus hepatitis following bone marrow transplantation. A case report and brief review of the literature</article-title><source>Arch Pathol Lab Med</source><volume>127</volume><year>2003</year><fpage>e246</fpage><lpage>e248</lpage><pub-id pub-id-type="pmid">12708923</pub-id></element-citation></ref><ref id="bib9"><label>9.</label><element-citation publication-type="journal" id="ref0050"><person-group person-group-type="author"><name><surname>Longerich</surname><given-names>T.</given-names></name><name><surname>Haferkamp</surname><given-names>K.</given-names></name><name><surname>Tox</surname><given-names>U.</given-names></name></person-group><article-title>Acute liver failure in a renal transplant patient caused by adenoviral hepatitis superimposed on a fibrosing cholestatic hepatitis B</article-title><source>Hum Pathol</source><volume>35</volume><year>2004</year><fpage>894</fpage><lpage>897</lpage><pub-id pub-id-type="pmid">15257556</pub-id></element-citation></ref><ref id="bib10"><label>10.</label><element-citation publication-type="journal" id="ref0055"><person-group person-group-type="author"><name><surname>Chau</surname><given-names>T.N.</given-names></name><name><surname>Lee</surname><given-names>K.C.</given-names></name><name><surname>Yao</surname><given-names>H.</given-names></name></person-group><article-title>SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases</article-title><source>Hepatology</source><volume>39</volume><year>2004</year><fpage>302</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">14767982</pub-id></element-citation></ref><ref id="bib11"><label>11.</label><element-citation publication-type="journal" id="ref0060"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>W.-F.</given-names></name><name><surname>To</surname><given-names>K.-F.</given-names></name><name><surname>Lam</surname><given-names>W.W.L.</given-names></name></person-group><article-title>The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1: a review</article-title><source>Hum Pathol</source><volume>37</volume><year>2006</year><fpage>381</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">16564911</pub-id></element-citation></ref><ref id="bib12"><label>12.</label><element-citation publication-type="journal" id="ref0065"><person-group person-group-type="author"><name><surname>Polakos</surname><given-names>N.K.</given-names></name><name><surname>Cornejo</surname><given-names>J.C.</given-names></name><name><surname>Murray</surname><given-names>D.A.</given-names></name></person-group><article-title>Kupfer cell-dependent hepatitis occurs during influenza infection</article-title><source>Am J Pathol</source><volume>168</volume><year>2006</year><fpage>1169</fpage><lpage>1178</lpage><pub-id pub-id-type="pmid">16565492</pub-id></element-citation></ref><ref id="bib13"><label>13.</label><element-citation publication-type="journal" id="ref0070"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>D.H.</given-names></name><name><surname>Hubscher</surname><given-names>S.G.</given-names></name></person-group><article-title>Systemic viral infections and collateral damage in the liver</article-title><source>Am J Pathol</source><volume>168</volume><year>2006</year><fpage>1057</fpage><lpage>1059</lpage><pub-id pub-id-type="pmid">16565481</pub-id></element-citation></ref><ref id="bib14"><label>14.</label><element-citation publication-type="journal" id="ref0075"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>J.Y.N.</given-names></name><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>Lai</surname><given-names>M.M.C.</given-names></name></person-group><article-title>Apoptosis and viral hepatitis</article-title><source>Semin Liver Dis</source><volume>18</volume><year>1998</year><fpage>169</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">9606813</pub-id></element-citation></ref><ref id="bib15"><label>15.</label><element-citation publication-type="journal" id="ref0080"><person-group person-group-type="author"><name><surname>Klotz</surname><given-names>O.</given-names></name><name><surname>Belt</surname><given-names>T.H.</given-names></name></person-group><article-title>The pathology of the liver in yellow fever</article-title><source>Am J Pathol</source><volume>6</volume><year>1930</year><fpage>663</fpage><lpage>689</lpage><pub-id pub-id-type="pmid">19969934</pub-id></element-citation></ref><ref id="bib16"><label>16.</label><element-citation publication-type="journal" id="ref0085"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>L.B.</given-names><suffix>Jr.</suffix></name><name><surname>Alves</surname><given-names>V.A.F.</given-names></name><name><surname>Kanamura</surname><given-names>C.</given-names></name></person-group><article-title>Fulminant hepatic failure in northern Brazil: morphological, immunohistochemical and pathogenic aspects of L&#x000e1;brea hepatitis and yellow fever</article-title><source>Trans Roy Soc Trop Med Hyg</source><volume>101</volume><year>2007</year><fpage>831</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">17568643</pub-id></element-citation></ref><ref id="bib17"><label>17.</label><element-citation publication-type="journal" id="ref0090"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>M.J.</given-names></name><name><surname>Blendis</surname><given-names>L.M.</given-names></name><name><surname>Poucell</surname><given-names>S.</given-names></name></person-group><article-title>Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course and paramyxoviral features</article-title><source>N Engl J Med</source><volume>324</volume><year>1991</year><fpage>455</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">1988831</pub-id></element-citation></ref><ref id="bib18"><label>18.</label><element-citation publication-type="journal" id="ref0095"><person-group person-group-type="author"><name><surname>Fimmel</surname><given-names>C.J.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Compans</surname><given-names>R.W.</given-names></name></person-group><article-title>A case of syncytial giant cell hepatitis with features of a paramyxoviral infection</article-title><source>Am J Gastroenterol</source><volume>93</volume><year>1998</year><fpage>1931</fpage><lpage>1937</lpage><pub-id pub-id-type="pmid">9772058</pub-id></element-citation></ref><ref id="bib19"><label>19.</label><element-citation publication-type="journal" id="ref0100"><person-group person-group-type="author"><name><surname>Devaney</surname><given-names>K.</given-names></name><name><surname>Goodman</surname><given-names>Z.D.</given-names></name><name><surname>Ishak</surname><given-names>K.G.</given-names></name></person-group><article-title>Postinfantile giant-cell transformation in hepatitis</article-title><source>Hepatology</source><volume>16</volume><year>1992</year><fpage>327</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">1639341</pub-id></element-citation></ref><ref id="bib20"><label>20.</label><element-citation publication-type="journal" id="ref0105"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>J.Y.N.</given-names></name><name><surname>Koukoulis</surname><given-names>G.</given-names></name><name><surname>Mieli-Vergani</surname><given-names>G.</given-names></name></person-group><article-title>Syncytial giant-cell hepatitis &#x02013; a specific disease entity?</article-title><source>J Hepatol</source><volume>15</volume><year>1992</year><fpage>216</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">1506641</pub-id></element-citation></ref><ref id="bib21"><label>21.</label><element-citation publication-type="journal" id="ref0110"><person-group person-group-type="author"><name><surname>Protzer</surname><given-names>U.</given-names></name><name><surname>Dienes</surname><given-names>H.P.</given-names></name><name><surname>Bianchi</surname><given-names>L.</given-names></name></person-group><article-title>Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis</article-title><source>Liver</source><volume>16</volume><year>1996</year><fpage>274</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">8878001</pub-id></element-citation></ref><ref id="bib22"><label>22.</label><element-citation publication-type="journal" id="ref0115"><person-group person-group-type="author"><name><surname>Ben-Ari</surname><given-names>Z.</given-names></name><name><surname>Broida</surname><given-names>E.</given-names></name><name><surname>Monselise</surname><given-names>Y.</given-names></name></person-group><article-title>Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+) presenting as subfulminant hepatitis</article-title><source>Am J Gastroenterol</source><volume>95</volume><year>2000</year><fpage>799</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">10710079</pub-id></element-citation></ref><ref id="bib23"><label>23.</label><element-citation publication-type="journal" id="ref0120"><person-group person-group-type="author"><name><surname>Micchelli</surname><given-names>S.T.L.</given-names></name><name><surname>Thomas</surname><given-names>D.</given-names></name><name><surname>Boitnott</surname><given-names>J.K.</given-names></name></person-group><article-title>Hepatic giant cells in hepatitis C virus (HCV) mono-infection and HCV/HIV co-infection</article-title><source>J Clin Pathol</source><volume>61</volume><year>2008</year><fpage>1058</fpage><lpage>1061</lpage><pub-id pub-id-type="pmid">18682418</pub-id></element-citation></ref><ref id="bib24"><label>24.</label><element-citation publication-type="journal" id="ref0125"><person-group person-group-type="author"><name><surname>Sciot</surname><given-names>R.</given-names></name><name><surname>Van Damme</surname><given-names>B.</given-names></name><name><surname>Desmet</surname><given-names>V.J.</given-names></name></person-group><article-title>Cholestatic features in hepatitis A</article-title><source>J Hepatol</source><volume>3</volume><year>1986</year><fpage>172</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">3025288</pub-id></element-citation></ref><ref id="bib25"><label>25.</label><element-citation publication-type="journal" id="ref0130"><person-group person-group-type="author"><name><surname>Volpes</surname><given-names>R.</given-names></name><name><surname>van den Oord</surname><given-names>J.J.</given-names></name><name><surname>Desmet</surname><given-names>V.J.</given-names></name></person-group><article-title>Memory T cells represent the predominant lymphocyte subset in acute and chronic liver inflammation</article-title><source>Hepatology</source><volume>13</volume><year>1991</year><fpage>826</fpage><lpage>829</lpage><pub-id pub-id-type="pmid">1674247</pub-id></element-citation></ref><ref id="bib26"><label>26.</label><element-citation publication-type="journal" id="ref0135"><person-group person-group-type="author"><name><surname>Mietkiewski</surname><given-names>J.M.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Immunoglobulin-containing plasma cells in acute hepatitis</article-title><source>Liver</source><volume>5</volume><year>1985</year><fpage>84</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">3889531</pub-id></element-citation></ref><ref id="bib27"><label>27.</label><element-citation publication-type="journal" id="ref0140"><person-group person-group-type="author"><name><surname>Bardadin</surname><given-names>K.A.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name></person-group><article-title>Endothelial cell changes in acute hepatitis. A light and electron microscopic study</article-title><source>J Pathol</source><volume>144</volume><year>1984</year><fpage>213</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">6502298</pub-id></element-citation></ref><ref id="bib28"><label>28.</label><element-citation publication-type="journal" id="ref0145"><person-group person-group-type="author"><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>Maggi</surname><given-names>G.</given-names></name></person-group><article-title>Hepatic fibrosis and collapse: histological distinction by orcein staining</article-title><source>Histopathology</source><volume>4</volume><year>1980</year><fpage>487</fpage><lpage>490</lpage><pub-id pub-id-type="pmid">6159296</pub-id></element-citation></ref><ref id="bib29"><label>29.</label><element-citation publication-type="journal" id="ref0150"><person-group person-group-type="author"><name><surname>Thung</surname><given-names>S.N.</given-names></name><name><surname>Gerber</surname><given-names>M.A.</given-names></name></person-group><article-title>The formation of elastic fibers in livers with massive hepatic necrosis</article-title><source>Arch Pathol Lab Med</source><volume>106</volume><year>1982</year><fpage>468</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">6896811</pub-id></element-citation></ref><ref id="bib30"><label>30.</label><element-citation publication-type="journal" id="ref0155"><person-group person-group-type="author"><name><surname>Hanau</surname><given-names>C.</given-names></name><name><surname>Munoz</surname><given-names>S.J.</given-names></name><name><surname>Rubin</surname><given-names>R.</given-names></name></person-group><article-title>Histopathological heterogeneity in fulminant hepatic failure</article-title><source>Hepatology</source><volume>21</volume><year>1995</year><fpage>345</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">7843704</pub-id></element-citation></ref><ref id="bib31"><label>31.</label><element-citation publication-type="journal" id="ref0160"><person-group person-group-type="author"><name><surname>Demetris</surname><given-names>A.J.</given-names></name><name><surname>Seaberg</surname><given-names>E.C.</given-names></name><name><surname>Wennerberg</surname><given-names>A.</given-names></name></person-group><article-title>Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes</article-title><source>Am J Pathol</source><volume>149</volume><year>1996</year><fpage>439</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">8701983</pub-id></element-citation></ref><ref id="bib32"><label>32.</label><element-citation publication-type="journal" id="ref0165"><person-group person-group-type="author"><name><surname>Roskams</surname><given-names>T.</given-names></name><name><surname>De Vos</surname><given-names>R.</given-names></name><name><surname>van Eyken</surname><given-names>P.</given-names></name></person-group><article-title>Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man</article-title><source>J Hepatol</source><volume>29</volume><year>1998</year><fpage>455</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">9764994</pub-id></element-citation></ref><ref id="bib33"><label>33.</label><element-citation publication-type="journal" id="ref0170"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Theise</surname><given-names>N.</given-names></name><name><surname>Chua</surname><given-names>M.</given-names></name></person-group><article-title>The stem cell niche of human livers: symmetry between development and regeneration</article-title><source>Hepatology</source><volume>48</volume><year>2008</year><fpage>1598</fpage><lpage>1607</lpage><pub-id pub-id-type="pmid">18972441</pub-id></element-citation></ref><ref id="bib34"><label>34.</label><element-citation publication-type="journal" id="ref0175"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>A.J.</given-names></name><name><surname>Saleh</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>H.</given-names></name></person-group><article-title>Late-onset hepatic failure: clinical features, serology and outcome following transplantation</article-title><source>J Hepatol</source><volume>23</volume><year>1995</year><fpage>363</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">8655952</pub-id></element-citation></ref><ref id="bib35"><label>35.</label><element-citation publication-type="journal" id="ref0180"><person-group person-group-type="author"><name><surname>Teixeira</surname><given-names>M.R.</given-names><suffix>Jr.</suffix></name><name><surname>Weller</surname><given-names>I.V.D.</given-names></name><name><surname>Murray</surname><given-names>A.M.</given-names></name></person-group><article-title>The pathology of hepatitis A in man</article-title><source>Liver</source><volume>2</volume><year>1982</year><fpage>53</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">7176838</pub-id></element-citation></ref><ref id="bib36"><label>36.</label><element-citation publication-type="journal" id="ref0185"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>H.</given-names></name><name><surname>Beninger</surname><given-names>P.R.</given-names></name><name><surname>Ikejiri</surname><given-names>N.</given-names></name></person-group><article-title>Light microscopic findings of liver biopsy specimens from patients with hepatitis type A and comparison with type B</article-title><source>Gastroenterology</source><volume>82</volume><year>1982</year><fpage>938</fpage><lpage>947</lpage><pub-id pub-id-type="pmid">6174391</pub-id></element-citation></ref><ref id="bib37"><label>37.</label><element-citation publication-type="journal" id="ref0190"><person-group person-group-type="author"><name><surname>Okuno</surname><given-names>T.</given-names></name><name><surname>Sano</surname><given-names>A.</given-names></name><name><surname>Deguchi</surname><given-names>T.</given-names></name></person-group><article-title>Pathology of acute hepatitis A in humans. Comparison with acute hepatitis B</article-title><source>Am J Clin Pathol</source><volume>81</volume><year>1984</year><fpage>162</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">6695857</pub-id></element-citation></ref><ref id="bib38"><label>38.</label><element-citation publication-type="journal" id="ref0195"><person-group person-group-type="author"><name><surname>Ponz</surname><given-names>E.</given-names></name><name><surname>Garcia-Pagan</surname><given-names>J.C.</given-names></name><name><surname>Bruguera</surname><given-names>M.</given-names></name></person-group><article-title>Hepatic fibrin-ring granulomas in a patient with hepatitis A</article-title><source>Gastroenterology</source><volume>100</volume><year>1991</year><fpage>268</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">1983832</pub-id></element-citation></ref><ref id="bib39"><label>39.</label><element-citation publication-type="journal" id="ref0200"><person-group person-group-type="author"><name><surname>Ruel</surname><given-names>M.</given-names></name><name><surname>Sevestre</surname><given-names>H.</given-names></name><name><surname>Henry-Biabaud</surname><given-names>E.</given-names></name></person-group><article-title>Fibrin ring granulomas in hepatitis A</article-title><source>Dig Dis Sci</source><volume>37</volume><year>1992</year><fpage>1915</fpage><lpage>1917</lpage><pub-id pub-id-type="pmid">1473440</pub-id></element-citation></ref><ref id="bib40"><label>40.</label><element-citation publication-type="journal" id="ref0205"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>K.</given-names></name><name><surname>Yoshiba</surname><given-names>M.</given-names></name><name><surname>Yotsuyanagi</surname><given-names>H.</given-names></name></person-group><article-title>Chronic hepatitis A with persistent viral replication</article-title><source>J Med Virol</source><volume>50</volume><year>1996</year><fpage>322</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">8950689</pub-id></element-citation></ref><ref id="bib41"><label>41.</label><element-citation publication-type="journal" id="ref0210"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>C.W.</given-names></name><name><surname>Hwang</surname><given-names>S.J.</given-names></name><name><surname>Luo</surname><given-names>J.C.</given-names></name></person-group><article-title>Comparison of clinical, virologic and pathologic features in patients with acute hepatitis B and C</article-title><source>J Gastroenterol Hepatol</source><volume>16</volume><year>2001</year><fpage>209</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">11207903</pub-id></element-citation></ref><ref id="bib42"><label>42.</label><element-citation publication-type="journal" id="ref0215"><person-group person-group-type="author"><name><surname>Uchida</surname><given-names>T.</given-names></name><name><surname>Shimojima</surname><given-names>S.</given-names></name><name><surname>Gotoh</surname><given-names>K.</given-names></name></person-group><article-title>Pathology of livers infected with &#x02018;silent&#x02019; hepatitis B virus mutant</article-title><source>Liver</source><volume>14</volume><year>1994</year><fpage>251</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">7997084</pub-id></element-citation></ref><ref id="bib43"><label>43.</label><element-citation publication-type="journal" id="ref0220"><person-group person-group-type="author"><name><surname>Yuki</surname><given-names>N.</given-names></name><name><surname>Nagaoka</surname><given-names>T.</given-names></name><name><surname>Yamashiro</surname><given-names>M.</given-names></name></person-group><article-title>Long-term histologic and virologic outcomes of acute self-limited hepatitis B</article-title><source>Hepatology</source><volume>37</volume><year>2003</year><fpage>1172</fpage><lpage>1179</lpage><pub-id pub-id-type="pmid">12717399</pub-id></element-citation></ref><ref id="bib44"><label>44.</label><element-citation publication-type="journal" id="ref0225"><person-group person-group-type="author"><name><surname>Bamber</surname><given-names>M.</given-names></name><name><surname>Murray</surname><given-names>A.</given-names></name><name><surname>Arborgh</surname><given-names>B.A.</given-names></name></person-group><article-title>Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders</article-title><source>Gut</source><volume>22</volume><year>1981</year><fpage>854</fpage><lpage>859</lpage><pub-id pub-id-type="pmid">6795093</pub-id></element-citation></ref><ref id="bib45"><label>45.</label><element-citation publication-type="journal" id="ref0230"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>K.</given-names></name><name><surname>Hashimoto</surname><given-names>E.</given-names></name><name><surname>Ludwig</surname><given-names>J.</given-names></name></person-group><article-title>Liver biopsy features of acute hepatitis C compared with hepatitis A, B and non-A, non-B, non-C</article-title><source>Liver</source><volume>13</volume><year>1993</year><fpage>69</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">8510489</pub-id></element-citation></ref><ref id="bib46"><label>46.</label><element-citation publication-type="journal" id="ref0235"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>C.M.</given-names></name><name><surname>Sheen</surname><given-names>I.S.</given-names></name><name><surname>Liaw</surname><given-names>Y.F.</given-names></name></person-group><article-title>The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B</article-title><source>Gastroenterology</source><volume>107</volume><year>1994</year><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">8020661</pub-id></element-citation></ref><ref id="bib47"><label>47.</label><element-citation publication-type="journal" id="ref0240"><person-group person-group-type="author"><name><surname>Govindarajan</surname><given-names>S.</given-names></name><name><surname>De-Cock</surname><given-names>K.M.</given-names></name><name><surname>Redeker</surname><given-names>A.G.</given-names></name></person-group><article-title>Natural course of delta superinfection in chronic hepatitis B virus-infected patients: histopathologic study with multiple liver biopsies</article-title><source>Hepatology</source><volume>6</volume><year>1986</year><fpage>640</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">3525368</pub-id></element-citation></ref><ref id="bib48"><label>48.</label><element-citation publication-type="journal" id="ref0245"><person-group person-group-type="author"><name><surname>Verme</surname><given-names>G.</given-names></name><name><surname>Amoroso</surname><given-names>P.</given-names></name><name><surname>Lettieri</surname><given-names>G.</given-names></name></person-group><article-title>A histological study of hepatitis delta virus liver disease</article-title><source>Hepatology</source><volume>6</volume><year>1986</year><fpage>1303</fpage><lpage>1307</lpage><pub-id pub-id-type="pmid">3793008</pub-id></element-citation></ref><ref id="bib49"><label>49.</label><element-citation publication-type="journal" id="ref0250"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.-H.</given-names></name><name><surname>Liaw</surname><given-names>Y.-F.</given-names></name><name><surname>Chen</surname><given-names>T.-J.</given-names></name></person-group><article-title>Natural course of patients with chronic type B hepatitis following acute hepatitis delta virus superinfection</article-title><source>Liver</source><volume>9</volume><year>1989</year><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">2747438</pub-id></element-citation></ref><ref id="bib50"><label>50.</label><element-citation publication-type="journal" id="ref0255"><person-group person-group-type="author"><name><surname>Moreno</surname><given-names>A.</given-names></name><name><surname>Ram&#x000f3;n</surname><given-names>Y.</given-names></name><name><surname>Cahal</surname><given-names>S.</given-names></name></person-group><article-title>Sanded nuclei in delta patients</article-title><source>Liver</source><volume>9</volume><year>1989</year><fpage>367</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">2558268</pub-id></element-citation></ref><ref id="bib51"><label>51.</label><element-citation publication-type="journal" id="ref0260"><person-group person-group-type="author"><name><surname>Smedile</surname><given-names>A.</given-names></name><name><surname>Farci</surname><given-names>P.</given-names></name><name><surname>Verme</surname><given-names>G.</given-names></name></person-group><article-title>Influence of delta infection on severity of hepatitis B</article-title><source>Lancet</source><volume>ii</volume><year>1982</year><fpage>945</fpage><lpage>947</lpage></element-citation></ref><ref id="bib52"><label>52.</label><element-citation publication-type="journal" id="ref0265"><person-group person-group-type="author"><name><surname>Popper</surname><given-names>H.</given-names></name><name><surname>Thung</surname><given-names>S.N.</given-names></name><name><surname>Gerber</surname><given-names>M.A.</given-names></name></person-group><article-title>Histologic studies of severe delta agent infection in Venezuelan Indians</article-title><source>Hepatology</source><volume>3</volume><year>1983</year><fpage>906</fpage><lpage>912</lpage><pub-id pub-id-type="pmid">6629319</pub-id></element-citation></ref><ref id="bib53"><label>53.</label><element-citation publication-type="journal" id="ref0270"><person-group person-group-type="author"><name><surname>Buitrago</surname><given-names>B.</given-names></name><name><surname>Popper</surname><given-names>H.</given-names></name><name><surname>Hadler</surname><given-names>S.C.</given-names></name></person-group><article-title>Specific histologic features of Santa Marta hepatitis: a severe form of hepatitis delta-virus infection in Northern South America</article-title><source>Hepatology</source><volume>6</volume><year>1986</year><fpage>1285</fpage><lpage>1291</lpage><pub-id pub-id-type="pmid">3793005</pub-id></element-citation></ref><ref id="bib54"><label>54.</label><element-citation publication-type="journal" id="ref0275"><person-group person-group-type="author"><name><surname>Lefkowitch</surname><given-names>J.H.</given-names></name><name><surname>Goldstein</surname><given-names>H.</given-names></name><name><surname>Yatto</surname><given-names>R.</given-names></name></person-group><article-title>Cytopathic liver injury in acute delta virus hepatitis</article-title><source>Gastroenterology</source><volume>92</volume><year>1987</year><fpage>1262</fpage><lpage>1266</lpage><pub-id pub-id-type="pmid">3557018</pub-id></element-citation></ref><ref id="bib55"><label>55.</label><element-citation publication-type="journal" id="ref0280"><person-group person-group-type="author"><name><surname>Rizzetto</surname><given-names>M.</given-names></name></person-group><article-title>Hepatitis D: thirty years after</article-title><source>J Hepatol</source><volume>50</volume><year>2009</year><fpage>1043</fpage><lpage>1050</lpage><pub-id pub-id-type="pmid">19285743</pub-id></element-citation></ref><ref id="bib56"><label>56.</label><element-citation publication-type="journal" id="ref0285"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>S.E.</given-names></name><name><surname>Lau</surname><given-names>J.Y.N.</given-names></name><name><surname>O&#x02019;Grady</surname><given-names>J.G.</given-names></name></person-group><article-title>Evidence that hepatitis D virus needs hepatitis B virus to cause hepatocellular damage</article-title><source>Am J Clin Pathol</source><volume>98</volume><year>1992</year><fpage>554</fpage><lpage>558</lpage><pub-id pub-id-type="pmid">1462952</pub-id></element-citation></ref><ref id="bib57"><label>57.</label><element-citation publication-type="journal" id="ref0290"><person-group person-group-type="author"><name><surname>Nimgoonkar</surname><given-names>I.</given-names></name><name><surname>Ding</surname><given-names>Q.</given-names></name><name><surname>Schwartz</surname><given-names>R.E.</given-names></name><name><surname>Ploss</surname><given-names>A.</given-names></name></person-group><article-title>Hepatitis E virus: advances and challenges</article-title><source>Nat Rev Gastroenterol Hepatol</source><volume>15</volume><year>2018</year><fpage>96</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">29162935</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal" id="ref9015"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>R.H.</given-names></name><name><surname>Emerson</surname><given-names>S.U.</given-names></name></person-group><article-title>Hepatitis E: an emerging awareness of an old disease</article-title><source>J Hepatol</source><volume>48</volume><year>2008</year><fpage>494</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">18192058</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal" id="ref9020"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>P.C.Y.</given-names></name><name><surname>Lau</surname><given-names>S.K.P.</given-names></name><name><surname>Teng</surname><given-names>J.L.L.</given-names></name></person-group><article-title>New hepatitis E virus genotype in camels, the Middle East</article-title><source>Emerg Inf Dis</source><volume>20</volume><year>2014</year><fpage>1044</fpage><lpage>1048</lpage></element-citation></ref><ref id="bib103"><mixed-citation publication-type="other" id="ceotherref0015">Kenney SP. The current host range of hepatitis E viruses. <italic>Viruses</italic>. 2019;11(5):452.https://doi:10.3390/v11050452.</mixed-citation></ref><ref id="bib104"><element-citation publication-type="journal" id="ref0300"><person-group person-group-type="author"><name><surname>Rein</surname><given-names>D.B.</given-names></name><name><surname>Stevens</surname><given-names>G.A.</given-names></name><name><surname>Theaker</surname><given-names>J.</given-names></name></person-group><article-title>The global burden of hepatitis E virus genotypes 1 and 2 in 2005</article-title><source>Hepatology</source><volume>55</volume><year>2012</year><fpage>988</fpage><lpage>997</lpage><pub-id pub-id-type="pmid">22121109</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal" id="ref9025"><person-group person-group-type="author"><name><surname>Hakim</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Bramer</surname><given-names>W.M.</given-names></name></person-group><article-title>The global burden of hepatitis E outbreaks: a systematic review</article-title><source>Liver Int</source><volume>37</volume><year>2017</year><fpage>19</fpage><lpage>31</lpage></element-citation></ref><ref id="bib60"><label>60.</label><element-citation publication-type="journal" id="ref0305"><person-group person-group-type="author"><name><surname>Malcolm</surname><given-names>P.</given-names></name><name><surname>Dalton</surname><given-names>H.</given-names></name><name><surname>Hussaini</surname><given-names>H.S.</given-names></name></person-group><article-title>The histology of acute autochthonous hepatitis E virus infection</article-title><source>Histopathology</source><volume>51</volume><year>2007</year><fpage>190</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">17650215</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal" id="ref0315"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>E.Y.</given-names></name><name><surname>Baum</surname><given-names>K.</given-names></name><name><surname>Collins</surname><given-names>W.</given-names></name></person-group><article-title>Hepatitis E masquerading as drug-induced liver injury</article-title><source>Hepatology</source><volume>56</volume><year>2012</year><fpage>2420</fpage><lpage>2423</lpage><pub-id pub-id-type="pmid">23175167</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal" id="ref9030"><person-group person-group-type="author"><name><surname>Davern</surname><given-names>T.J.</given-names></name><name><surname>Chalasani</surname><given-names>N.</given-names></name><name><surname>Fontana</surname><given-names>R.J.</given-names></name></person-group><article-title>Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury</article-title><source>Gastroenterology</source><volume>141</volume><year>2011</year><fpage>1665</fpage><lpage>1672</lpage><pub-id pub-id-type="pmid">21855518</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal" id="ref9035"><person-group person-group-type="author"><name><surname>Memon</surname><given-names>A.</given-names></name><name><surname>Miranda</surname><given-names>J.</given-names></name></person-group><article-title>Hepatitis E virus infection in a patient with suspected drug-induced liver injury</article-title><source>BMJ Case Rep</source><year>2017</year><pub-id pub-id-type="doi">10.1136/bcr-2016-218387</pub-id></element-citation></ref><ref id="bib62"><label>62.</label><element-citation publication-type="journal" id="ref0310"><person-group person-group-type="author"><name><surname>Lenggenhager</surname><given-names>D.</given-names></name><name><surname>Weber</surname><given-names>A.</given-names></name></person-group><article-title>Hepatitis E virus and the liver: clinical settings and liver pathology</article-title><source>Gastroenterol Clin N Am</source><volume>46</volume><year>2017</year><fpage>393</fpage><lpage>408</lpage></element-citation></ref><ref id="bib109"><element-citation publication-type="journal" id="ref0320"><person-group person-group-type="author"><name><surname>Hamid</surname><given-names>S.S.</given-names></name><name><surname>Atiq</surname><given-names>M.</given-names></name><name><surname>Shehzad</surname><given-names>F.</given-names></name></person-group><article-title>Hepatitis E virus superinfection in patients with chronic liver disease</article-title><source>Hepatology</source><volume>36</volume><year>2002</year><fpage>474</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">12143058</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal" id="ref9040"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>G.-H.</given-names></name><name><surname>Tan</surname><given-names>B.-H.</given-names></name><name><surname>Chi-Yuan</surname><given-names>E.</given-names></name></person-group><article-title>Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk</article-title><source>Gastroenterology</source><volume>150</volume><year>2016</year><fpage>355</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">26551551</pub-id></element-citation></ref><ref id="bib111"><mixed-citation publication-type="other" id="ceotherref0020">Lenggenhager D, Weber A. Clinicopathologic features and pathologic diagnosis of hepatitis E. <italic>Hum Pathol</italic>. https://doi:10.1016/j.humpath.2019.10.003.</mixed-citation></ref><ref id="bib64"><label>64.</label><element-citation publication-type="journal" id="ref0325"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>J.</given-names></name><name><surname>Eapen</surname><given-names>C.E.</given-names></name><name><surname>Kang</surname><given-names>G.</given-names></name></person-group><article-title>Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease</article-title><source>J Gastroenterol Hepatol</source><volume>19</volume><year>2004</year><fpage>134</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">14731121</pub-id></element-citation></ref><ref id="bib65"><label>65.</label><element-citation publication-type="journal" id="ref0330"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N.</given-names></name><name><surname>Selves</surname><given-names>J.</given-names></name><name><surname>Mansuy</surname><given-names>J.-M.</given-names></name></person-group><article-title>Hepatitis E virus and chronic hepatitis in organ-transplant recipients</article-title><source>N Engl J Med</source><volume>358</volume><year>2008</year><fpage>811</fpage><lpage>817</lpage><pub-id pub-id-type="pmid">18287603</pub-id></element-citation></ref><ref id="bib66"><label>66.</label><element-citation publication-type="journal" id="ref0335"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N.</given-names></name><name><surname>Mansuy</surname><given-names>J.-M.</given-names></name><name><surname>Cointault</surname><given-names>O.</given-names></name></person-group><article-title>Hepatitis E virus-related cirrhosis in kidney- and kidney&#x02013;pancreas-transplant recipients</article-title><source>Am J Transplant</source><volume>8</volume><year>2008</year><fpage>1744</fpage><lpage>1748</lpage><pub-id pub-id-type="pmid">18557740</pub-id></element-citation></ref><ref id="bib67"><label>67.</label><element-citation publication-type="journal" id="ref0340"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>R.</given-names></name></person-group><article-title>Hepatitis E: does it cause chronic hepatitis?</article-title><source>Hepatology</source><volume>48</volume><year>2008</year><fpage>1328</fpage><lpage>1330</lpage><pub-id pub-id-type="pmid">18821611</pub-id></element-citation></ref><ref id="bib68"><label>68.</label><element-citation publication-type="journal" id="ref0355"><person-group person-group-type="author"><name><surname>Dienes</surname><given-names>H.P.</given-names></name><name><surname>H&#x000fc;tteroth</surname><given-names>T.</given-names></name><name><surname>Bianchi</surname><given-names>L.</given-names></name></person-group><article-title>Hepatitis A-like non-A, non-B hepatitis: light and electron microscopic observations of three cases</article-title><source>Virchows Arch A Pathol Anat Histopathol</source><volume>409</volume><year>1986</year><fpage>657</fpage><lpage>667</lpage><pub-id pub-id-type="pmid">3092461</pub-id></element-citation></ref><ref id="bib69"><label>69.</label><element-citation publication-type="journal" id="ref0365"><person-group person-group-type="author"><name><surname>Asher</surname><given-names>L.V.S.</given-names></name><name><surname>Innis</surname><given-names>B.L.</given-names></name><name><surname>Shrestha</surname><given-names>M.P.</given-names></name></person-group><article-title>Virus-like particles in the liver of a patient with fulminant hepatitis and antibody to hepatitis E virus</article-title><source>J Med Virol</source><volume>31</volume><year>1990</year><fpage>229</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">2391510</pub-id></element-citation></ref><ref id="bib70"><label>70.</label><element-citation publication-type="journal" id="ref9045"><person-group person-group-type="author"><name><surname>Beer</surname><given-names>A.</given-names></name><name><surname>Holzmann</surname><given-names>H.</given-names></name><name><surname>Pischke</surname><given-names>S.</given-names></name></person-group><article-title>Chronic hepatitis E is associated with cholangitis</article-title><source>Liver Int</source><volume>39</volume><year>2019</year><fpage>1876</fpage><lpage>1883</lpage><pub-id pub-id-type="pmid">31102493</pub-id></element-citation></ref><ref id="bib71"><label>71.</label><element-citation publication-type="journal" id="ref9050"><person-group person-group-type="author"><name><surname>Lenggenhager</surname><given-names>D.</given-names></name><name><surname>Gouttenoire</surname><given-names>J.</given-names></name><name><surname>Malehmir</surname><given-names>M.</given-names></name></person-group><article-title>Visualization of hepatitis E virus RNA and proteins in the human liver</article-title><source>J Hepatol</source><volume>67</volume><year>2017</year><fpage>471</fpage><lpage>479</lpage><pub-id pub-id-type="pmid">28412294</pub-id></element-citation></ref><ref id="bib72"><label>72.</label><element-citation publication-type="journal" id="ref9055"><person-group person-group-type="author"><name><surname>Prost</surname><given-names>S.</given-names></name><name><surname>Crossan</surname><given-names>C.L.</given-names></name><name><surname>Dalton</surname><given-names>H.R.</given-names></name></person-group><article-title>Detection of viral hepatitis E in clinical liver biopsies</article-title><source>Histopathology</source><volume>71</volume><year>2017</year><fpage>580</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">28543644</pub-id></element-citation></ref><ref id="bib73"><label>73.</label><mixed-citation publication-type="other" id="ceotherref0025">Innis BL, Lynch JA. Immunization against hepatitis E. <italic>Cold Spring Harb Perspect Med</italic> 2018;8(11). https://doi:10.1101/cshperspect.a032573.</mixed-citation></ref><ref id="bib74"><label>74.</label><element-citation publication-type="journal" id="ref9060"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name></person-group><article-title>Prophylactic hepatitis E vaccines: antigenic analysis and serological evaluation</article-title><source>Viruses</source><volume>12</volume><year>2020</year><fpage>109</fpage><pub-id pub-id-type="doi">10.3390/v12010109</pub-id></element-citation></ref><ref id="bib75"><label>75.</label><element-citation publication-type="journal" id="ref9065"><person-group person-group-type="author"><name><surname>Melga&#x000e7;o</surname><given-names>J.G.</given-names></name><name><surname>Gardinalli</surname><given-names>N.R.</given-names></name><name><surname>Motta de Mello</surname></name><name><surname>Leal</surname><given-names>M.</given-names></name><name><surname>Lewis-Ximenez</surname><given-names>L.L.</given-names></name><name><surname>Pinto</surname><given-names>M.A.</given-names></name></person-group><article-title>Hepatitis E: update on prevention and control</article-title><source>Biomed Res Int</source><year>2018</year><fpage>5769201</fpage><pub-id pub-id-type="pmid">29546064</pub-id></element-citation></ref><ref id="bib76"><label>76.</label><element-citation publication-type="journal" id="ref9070"><person-group person-group-type="author"><name><surname>Desai</surname><given-names>A.</given-names></name><name><surname>Sandhu</surname><given-names>S.</given-names></name><name><surname>Lai</surname><given-names>J.-P.</given-names></name><name><surname>Sandhu</surname><given-names>D.S.</given-names></name></person-group><article-title>Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review</article-title><source>World J Hepatol</source><volume>11</volume><year>2019</year><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">30705715</pub-id></element-citation></ref><ref id="bib77"><label>77.</label><element-citation publication-type="journal" id="ref9075"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>M.</given-names></name><name><surname>Anstee</surname><given-names>Q.M.</given-names></name></person-group><article-title>Editorial: hepatocellular carcinoma in non-cirrhotic NASH&#x02014;a troubling reality</article-title><source>Aliment Pharmacol Ther</source><volume>48</volume><year>2018</year><fpage>1021</fpage><lpage>1023</lpage><pub-id pub-id-type="pmid">30318679</pub-id></element-citation></ref><ref id="bib78"><label>78.</label><element-citation publication-type="journal" id="ref9080"><person-group person-group-type="author"><name><surname>Stine</surname><given-names>J.G.</given-names></name><name><surname>Wentworth</surname><given-names>B.J.</given-names></name><name><surname>Zimmet</surname><given-names>A.</given-names></name></person-group><article-title>Systemic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases</article-title><source>Aliment Pharmacol Ther</source><volume>48</volume><year>2018</year><fpage>696</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">30136293</pub-id></element-citation></ref></ref-list><ref-list id="fread0010"><title>General reading</title><ref id="fur1"><element-citation publication-type="journal" id="ref0375"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>B.Y.</given-names></name><name><surname>Kim</surname><given-names>W.R.</given-names></name></person-group><article-title>Epidemiology of hepatitis B virus infection in the United States</article-title><source>Clin Liver Dis</source><volume>12</volume><year>2018</year><fpage>1</fpage><lpage>3</lpage></element-citation></ref><ref id="fur2"><element-citation publication-type="journal" id="ref0380"><person-group person-group-type="author"><name><surname>Lenggenhager</surname><given-names>D.</given-names></name><name><surname>Weber</surname><given-names>A.</given-names></name></person-group><article-title>Hepatitis E virus and the liver: clinical settings and liver pathology</article-title><source>Gastroenterol Clin N Am</source><volume>46</volume><year>2017</year><fpage>393</fpage><lpage>408</lpage></element-citation></ref><ref id="fur3"><element-citation publication-type="journal" id="ref0385"><person-group person-group-type="author"><name><surname>Morozov</surname><given-names>V.A.</given-names></name><name><surname>Lagaye</surname><given-names>S.</given-names></name></person-group><article-title>Hepatitis C virus: morphogenesis, infection and therapy</article-title><source>World J Hepatol</source><volume>10</volume><year>2018</year><fpage>186</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">29527256</pub-id></element-citation></ref><ref id="fur4"><element-citation publication-type="journal" id="ref9390"><person-group person-group-type="author"><name><surname>Nimgaonkar</surname><given-names>I.</given-names></name><name><surname>Ding</surname><given-names>Q,.</given-names></name><name><surname>Schwartz</surname><given-names>R.E.</given-names></name><name><surname>Ploss</surname><given-names>A.</given-names></name></person-group><article-title>Hepatitis E virus: advances and challenges</article-title><source>Nat Rev Gastroenterol Hepatol</source><volume>15</volume><year>2018</year><fpage>96</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">29162935</pub-id></element-citation></ref><ref id="fur5"><element-citation publication-type="journal" id="ref0395"><person-group person-group-type="author"><name><surname>Schmid</surname><given-names>R.</given-names></name></person-group><article-title>History of viral hepatitis: a tale of dogmas and misinterpretations</article-title><source>J Gastroenterol Hepatol</source><volume>16</volume><year>2001</year><fpage>718</fpage><lpage>722</lpage><pub-id pub-id-type="pmid">11446877</pub-id></element-citation></ref><ref id="fur6"><element-citation publication-type="book" id="ref0400"><person-group person-group-type="author"><name><surname>Theise</surname><given-names>N.D.</given-names></name><name><surname>Bodenheimer</surname><given-names>H.C.</given-names><suffix>Jr.</suffix></name><name><surname>Guido</surname><given-names>M.</given-names></name></person-group><chapter-title>Viral hepatitis</chapter-title><person-group person-group-type="editor"><name><surname>Burt</surname><given-names>A.D.</given-names></name><name><surname>Ferrell</surname><given-names>L.D.</given-names></name><name><surname>H&#x00171;bscher</surname><given-names>S.G.</given-names></name></person-group><source>MacSween&#x02019;s Pathology of the Liver</source><edition>7th ed.</edition><year>2018</year><publisher-name>Elsevier</publisher-name><publisher-loc>Philadelphia, PA</publisher-loc><fpage>372</fpage><lpage>415</lpage></element-citation></ref></ref-list></back></article>